Overview

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether RNS60 is effective in the treatment of RR-MS compared to interferon beta-1a.
Phase:
Phase 2
Details
Lead Sponsor:
Revalesio Corporation
Treatments:
Interferon beta-1a
Interferon-beta
Interferons
RNS60